BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1762085)

  • 41. [Effect of iodinated roentgen contrast media on coagulation, fibrinolysis and platelets].
    Schulze B; Riester P; Blanke D; Fees K; Lehnard G
    Arzneimittelforschung; 1977; 27(11):2128-33. PubMed ID: 580014
    [No Abstract]   [Full Text] [Related]  

  • 42. Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature.
    Welsh JD; Poventud-Fuentes I; Sampietro S; Diamond SL; Stalker TJ; Brass LF
    J Thromb Haemost; 2017 Mar; 15(3):526-537. PubMed ID: 27992950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clotting and fibrinolysis.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():50-3. PubMed ID: 182726
    [No Abstract]   [Full Text] [Related]  

  • 44. Rheological studies of the contractile force within platelet-fibrin clots: effects of prostaglandin E1, dibutyryl-cAMP and dibutyryl-cGMP.
    Kuntamukkula MS; McIntire LV; Moake JL; Peterson DM; Thompson WJ
    Thromb Res; 1978 Dec; 13(6):957-69. PubMed ID: 219559
    [No Abstract]   [Full Text] [Related]  

  • 45. Incomplete transformation of plasma fibrinogen to fibrin. Fibrinogen content and streptokinase-induced intra-clot lysis susceptibility of des-AA or des-AABB fibrin clots formed at varying fibrinogen/fibrin ratios.
    Brosstad F; Godal HC
    Thromb Res; 1979; 14(2-3):507-12. PubMed ID: 442019
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluorescent peptide for detecting factor XIIIa activity and fibrin in whole blood clots forming under flow.
    Liu Y; Crossen J; Stalker TJ; Diamond SL
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102291. PubMed ID: 38222077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.
    Berny MA; Munnix IC; Auger JM; Schols SE; Cosemans JM; Panizzi P; Bock PE; Watson SP; McCarty OJ; Heemskerk JW
    PLoS One; 2010 Apr; 5(4):e10415. PubMed ID: 20454680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Biochemical aspects of the streptokinase effect].
    Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):437-44. PubMed ID: 63431
    [No Abstract]   [Full Text] [Related]  

  • 49. Biochemical comparison of intermittent streptokinase and intermittent streptokinase plasminogen therapy.
    Barlow GH; Kakkar VV; Bentley PG; Chan PS; Jones NA; Mistry FD
    Thromb Res; 1979; 15(1-2):135-42. PubMed ID: 483271
    [No Abstract]   [Full Text] [Related]  

  • 50. Platelet inhibition of renal cortical fibrinolytic activity in the rabbit.
    Bergstein JM
    Lab Invest; 1976 Aug; 35(2):171-8. PubMed ID: 785093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrinolysis: an illustrated review.
    Risman RA; Kirby NC; Bannish BE; Hudson NE; Tutwiler V
    Res Pract Thromb Haemost; 2023 Feb; 7(2):100081. PubMed ID: 36942151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of plasma hemostasis on insulin action in vitro.
    Kleniewski J
    Endocrinol Exp; 1975 Sep; 9(3):223-7. PubMed ID: 1081045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots.
    Zubairova LD; Nabiullina RM; Nagaswami C; Zuev YF; Mustafin IG; Litvinov RI; Weisel JW
    Sci Rep; 2015 Dec; 5():17611. PubMed ID: 26635081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement of endothelial fibrinolytic activity in aorta and vena cava in rabbits: a fibrin-agar plate method.
    Kamio A; Shiraishi M; Shitama K; Sugimoto Y; Honda K; Takebayashi S
    Artery; 1979 Jan; 5(1):76-89. PubMed ID: 575477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Thrombolytic and pharmacodynamic properties of Aspergillus ochraceus protease].
    Klöcking HP; Markwardt F
    Farmakol Toksikol; 1975; 38(3):341-9. PubMed ID: 1084284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The human plasma fibrinolytic system: regulation and control.
    Robbins KC
    Mol Cell Biochem; 1978 Aug; 20(3):149-57. PubMed ID: 151804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological effects of fibrinogen-fibrin degradation products.
    Larrieu MJ; Dray L; Ardaillou N
    Thromb Diath Haemorrh; 1975 Dec; 34(3):686-92. PubMed ID: 1108283
    [No Abstract]   [Full Text] [Related]  

  • 58. [Evaluation of a method of study of platelet aggregates using formol fixation].
    Stoltz JF; Streiff F; Guerlet B; Larcan A; Vera JC
    Ann Biol Clin (Paris); 1977; 35(4):339-41. PubMed ID: 564152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New aspects of anastomoses of severed peripheral nerves].
    Duspiva W
    Fortschr Med; 1978 Nov; 96(43):2214-8. PubMed ID: 361529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Various aspects of the platelets-urokinase interaction].
    Bastida E; Villaverde CA; Borruel MT; Valdecasas FG
    Arch Farmacol Toxicol; 1979 Dec; 5(3):270-1. PubMed ID: 397805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.